Infinity Bio

Infinity Bio is a biotechnology company that pioneers large-scale mapping of immune responses, using its proprietary antibody response analysis platform to provide detailed insights into the immune system. The company's core technology, MIPSA, is used for comprehensive analysis of antibody responses, revealing individual immune response targets against all known human viruses, human proteins (autoimmune), and allergenic proteins. Developed by the Precision Immunology Laboratory at Johns Hopkins University, MIPSA builds on decades of work in genomics, proteomics, immunology, and bioinformatics. Infinity Bio’s assays are designed to achieve top-tier quality, data accuracy, turnaround time, and cost-effectiveness.